SCHEMBL4823872

SCHEMBL4823872

Cc1cc(NCCNS(=O)(=O)c2ccccc2)ccc1N

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
KMT2A Q03164 5/20 0.56
MEN1 O00255 3/20 0.56
RAB9A P51151 1/20 0.49
MAPT P10636 1/20 0.48
FFAR4 Q5NUL3 2/20 0.48
PKM P14618 4/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
USP2 O75604 1/20 0.44
MAPK1 P28482 1/20 0.43
CYTH2 Q99418 1/20 0.43
PRMT1 Q99873 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4822315 0.81 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1RAB9AMAPT
SCHEMBL6100186 0.80 ALDH1A1 (0.44) ALDH1A1KMT2AMEN1RAB9AMAPT
SCHEMBL4823307 0.80 ALDH1A1 (0.65) ALDH1A1KMT2AMEN1RAB9AMAPT
SCHEMBL10572974 0.80 FFAR4 (0.68) ALDH1A1KMT2AMEN1FFAR4PKM
SCHEMBL2126641 0.79 CYP3A4 (0.53) ALDH1A1MAPTTDP1MAPK1
Sulfuric Acid SCHEMBL3453574 0.78 ALDH1A1 (0.42) ALDH1A1KMT2AMEN1RAB9AMAPT
Sulfuric Acid SCHEMBL11318250 0.77 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1RAB9AMAPT
Sulfuric Acid SCHEMBL7031463 0.77 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1RAB9AMAPT
SCHEMBL4817793 0.76 ALDH1A1 (0.50) ALDH1A1KMT2AMEN1MAPTPKM
SCHEMBL14253805 0.75 ALDH1A1 (0.44) ALDH1A1KMT2AMEN1MAPTFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7347879-B2 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'Oreál, S.A. (FR) 2008-03-25 US claimed
US-20060005321-A1 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'OREAL S.A. (FR) 2006-01-12 US claimed
EP-1568687-A1 Sulphur-containing secondary para-Phenylenediamines, dying composition containing such para-phenylenediamines and methods using this composition and use L'OREAL (FR) 2005-08-31 EP claimed
US-7347879-B2 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'Oreál, S.A. (FR) 2008-03-25 US disclosed
US-7347879-B2 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'Oreál, S.A. (FR) 2008-03-25 US disclosed
US-7347879-B2 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'Oreál, S.A. (FR) 2008-03-25 US disclosed
US-20060005321-A1 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof L'OREAL S.A. (FR) 2006-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060005321-A1 Sulfur-containing secondary para-phenylenediamines dye compositions comprising such para-phenylenediamines, processes, and uses thereof KRT18, CDC73, DSG1 ALDH1A1 1148/4885KMT2A 2395/4885MEN1 3813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.